Home | Member Area

 Join the Roundtable
 About this Site
 Who We Are
 Call to Action
 Board of Directors
 Roundtable Update
 Reports & Studies
 Annual Conference
 Roundtable News
 Special Features

 Roundtable Policies
 Position Papers

 Tool Box
 Change Log-In
 Call or Write

Welcome to the Public Sector HealthCare Roundtable

About the Roundtable

Millions of Americans receive health care benefits as a result of their employment by state, county and local governmental units. The passage of the Affordable Care Act represents a historic opportunity to improve quality and increase value within the American health care system. However, the cost to provide this essential health care protection - to active and retired employees and to taxpayers - continues to increase at a challenging rate.

The Public Sector HealthCare Roundtable is a non-partisan, member-directed grassroots coalition that exists to give public employers and their health plan administrators a voice in this critical national discussion and to ensure that the public sector is not ignored in any federal action. As implementation of the Affordable Care Act continues, the Roundtable provides its members with a forum in which to share critical information and experiences and to consider potential partnerships that could improve efficiency and increase value.

Every public sector health care purchaser should consider joining today. For more information, visit our Join the Roundtable page.

Register Today for the
13th Annual Roundtable Conference
Nov. 1-3, 2017

The Public Sector HealthCare Roundtable's 13th Annual Conference is scheduled for Nov. 1-3, 2016, at The Alexandrian in the heart of Old Town Alexandria, Va.

This year's session topics will include:
  • Congressional Action: Health Care Reform Efforts and the Impact on Public Purchasers
  • Containing Drug Costs: Administration, Congressional and Public Purchaser Action
  • Insurance Markets and Coverage: Stabilization, Premium Levels and Plan Options
  • Delivery Reform and Value-Based Purchasing: Updates and Forecasts from CMS
  • The Cadillac Tax: Assessing Repeal Efforts and Advocacy Strategies
  • Quality and Comparative Effectiveness Research: Tools for Public Purchasers
  • The FDA and Accelerated Innovation: Safety, Access and the 21st Century Cures Act
  • The CMS Innovation Center: What Are We Learning and How Can We Use It?
  • Successful Advocacy: High-Impact Strategies and Tactics to Influence Policy and Politics
Register today and make your reservation at The Alexandrian by Oct. 4 to get the special conference rate of $229 a night.

For more information about the conference, click here.

Featured Resources
HealthCare Roundtable e-News - Aug. 25, 2017
  • CBO Defends Health Care Projections to Congressman
  • Democrats Question Administration on Plans for Exchanges
  • Doctors to Know Some ACO Patients
  • FDA Approves 6th Biosimilar
. . .

Recent Roundtable Activity

July 27, 2017
Roundtable Advocates for Bill to Protect Generic Drug Development
"To ensure that generic drug developers are not prevented by a small handful of brand companies from obtaining samples necessary to bring new accessible generic and biosimilar drugs to patients and payors, congressional action is necessary."

July 17, 2017
Roundtable Says It Is 'Deeply Concerned' About GOP Health Care Proposals
"Both legislative vehicles work against the policy priorities of the Roundtable ... and would have a severe deleterious impact on public sector workers, retirees, and their dependents, as well as the state and local taxpayers who fund their benefits."

May 19, 2017
Roundtable Supports CHRONIC Care Act
"We commend the Committee and the Working Group on its hard work and commitment to the development of bipartisan solutions to address the needs of the millions of Americans living with chronic medical conditions."

May 18, 2017
Roundtable Seeks Changes to Biosimilar Interchangeability Guidance
"Any applications which demonstrate that the product can be expected to produce the same clinical results as the reference product in any given patient, as required by statute should be deemed interchangeable."

April 27, 2017
Roundtable Backs Legislation to Stop REMS Abuses
"These abuses are growing and the resulting delay in generic and biosimilars competition is costing patients, the federal government, and the health care system billions of dollars annually."

April 6, 2017
Roundtable Supports Bill to Expand Development of Generic Drugs
"The bill would provide a clear solution to abusive, anticompetitive business practices that increase costs to the American health care system by impeding patient access to generic and biosimilar medicines."

Jan. 25, 2017
Roundtable Backs Move Toward Value-Based Care
"Through private and public sector alignment, the move toward value-based care is succeeding, measurably improving healthcare quality and contributing to historically low costs. Now is not the time for policymakers to signal a shift away from value-based care, either through action or inaction."

Sept. 27, 2016
Roundtable Seeks to Block Increases in Medicare Part B Premiums, Deductibles
"We are deeply concerned by the projected Part B premium and deductible increases, most notably for current and newly eligible beneficiaries living on low and fixed incomes. In 2014, half of the Medicare population lived on annual incomes of $24,150 or less. Newly enrolled Medicare beneficiaries, those not collecting Social Security benefits - many of whom are retired public servants - and state Medicaid programs should not be expected to carry the burden of paying for increased costs in Part B through higher premiums and cost sharing."

June 27, 2016
Roundtable Urges Lawmakers to Support Medicare Part B Payment Proposal
"Our support for the model is informed by our shared commitment to bipartisan efforts to transition Medicare from a volume-based system to one that reimburses based on health care quality and innovation."

June 14, 2016
Roundtable Backs Bill to Stop 'Anticompetitive' Practices by Brand Name Drug Companies
"The bill would provide a clear solution to abusive, anticompetitive business practices that increase costs to the American health care system by impeding patient access to generic medicines."

Jan. 28, 2016
Roundtable Submits Comments on Chronic Care Options Paper
"The Roundtable supports the efforts of the Working Group and believe the Policy Options Document reflects work and analysis that will further the goal of improving care for the millions of vulnerable Medicare beneficiaries managing multiple chronic conditions."